Therapeutics stock price
Webb13 apr. 2024 · The company’s stock has been forecasted to trade at an average price of $10.69 over the course of the next 52 weeks, with a low of $4.20 and a high of $16.00. Based on these price targets, the low is -208.82% off current price, whereas the price has to move -1076.47% to reach the yearly target high. WebbCerevel Therapeutics started at overweight with $50 stock price target at J.P. Morgan Jan. 5, 2024 at 7:15 a.m. ET by Tomi Kilgore Cerevel Therapeutics stock price target raised to …
Therapeutics stock price
Did you know?
WebbFör 1 dag sedan · A prescription digital therapeutics company, Better Therapeutics ( NASDAQ: BTTX ) stock price scaled 8% on Wednesday late hours as the company announced a private placement of ~7.88M shares... Webb14 apr. 2024 · Virios Therapeutics Inc. (NASDAQ:VIRI) shares, rose in value on Thursday, 04/13/23, with the stock price up by 6.56% to the previous day’s close as strong demand from buyers drove the stock to $0.60. Actively observing the price movement in the last trading, the stock closed the session at $0.57, falling within a range of $0.57 and $0.684.
Webb14 apr. 2024 · 14 April 2024, 3:13 am · 2-min read CRISPR Therapeutics AG CRSP shares soared 16.3% in the last trading session to close at $50.56. The move was backed by … Webbför 19 timmar sedan · Pre-clinical biopharmaceutical company, CytoMed Therapeutics (GDTC) prices its initial public offering of its 2.41M shares at a price of $4.00 per …
WebbTG Therapeutics stock price target raised to $25 from $16 at Evercore ISI Jan. 24, 2024 at 7:16 a.m. ET by Tomi Kilgore TG Therapeutics stock price target raised to $23 from $17 … WebbStrand Therapeutics is an emerging biopharmaceutical company applying synthetic biology to RNA therapeutics and developing the first platform for the creation of …
Webb13 apr. 2024 · Fate Therapeutics (Nasdaq:FATE) - Stock Price, News & Analysis - Simply Wall St Stocks / United States / Pharmaceuticals & Biotech Fate Therapeutics NasdaqGM:FATE Stock Report Last Price US$5.64 Market Cap US$553.6m 7D 2.0% 1Y -84.7% Updated 11 Apr, 2024 Data Company Financials + 23 Analysts FATE Stock Overview
Webb12 apr. 2024 · Shares of Eterna Therapeutics Inc. ( NASDAQ:ERNA – Get Rating) traded down 3.5% during trading on Tuesday . The company traded as low as $3.25 and last … csfd step by stepWebbför 2 dagar sedan · In recent trading, shares of TG Therapeutics Inc (Symbol: TGTX) have crossed above the average analyst 12-month target price of $20.78, changing hands for … csfd temne hmotyWebbContext Therapeutics And 3 Other Stocks Under $1 Insiders Are Aggressively Buying Jan. 24, 2024 at 6:49 a.m. ET on Benzinga.com Myomo, Enzo Biochem And These 2 Stocks Under $2 Insiders Are... csfd strachWebbFör 1 dag sedan · A prescription digital therapeutics company, Better Therapeutics (BTTX) stock price scaled 8% on Wednesday late hours as the company announced a private … csfd stripkyWebb13 apr. 2024 · The company’s stock has been forecasted to trade at an average price of $20.50 over the course of the next 52 weeks, with a low of $13.00 and a high of $30.00. Based on these price targets, the low is -30.39% off current price, whereas the price has to move -200.9% to reach the yearly target high. csfd station mapWebbFör 1 dag sedan · Bankrupt drugmaker Sorrento Therapeutics Inc.’s subsidiary Scilex Holding Co. is exploring a sale of new stock to take advantage of a share-price rally as … dythomas44 gmail.comhttp://stocktwits.com/symbol/ATOS dy thi